The growing global demand for precision medicine, coupled with the escalating prevalence of cancer and other chronic diseases, is significantly fueling the expansion of the DNA methylation detection technology market. Improvements in sequencing methods, particularly those offering higher throughput and reduced cost, are also contributing to market